CompareMarketResearchRequest a sample
Home / Healthcare / Hospital-at-Home Vital Signs Monitoring Platforms

Healthcare · Market report

Hospital-at-Home Vital Signs Monitoring Platforms Market Size, Share and Forecast 2026-2036

The global hospital-at-home vital signs monitoring platforms market is worth USD 614 mn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Wearables and monitoring devices is the largest by component segment.

USD 614 mnMarket size 2026
USD 2.5 bnForecast 2036
15.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global hospital-at-home vital signs monitoring platforms market is worth USD 614 mn in 2026 and is forecast to reach USD 2.5 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Wearables and monitoring devices is the largest by component segment.

ScopePlatforms that monitor acutely ill patients treated at home: wearable sensors, connected vital-sign kits, software dashboards and clinical integration services for hospital-at-home programmes.
IndustryHealthcare
Value 2025USD 520 mn
Value 2026USD 614 mn
Value 2036USD 2.5 bn
CAGR 2026-203615.0%
Volume 20261,788 thousand patient episodes
Volume 20367,998 thousand patient episodes
Average price 2026USD 343 per patient episode
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Hospital-at-Home Vital Signs Monitoring Platforms market size and forecast, 2026-2036

Exhibit 1The global hospital-at-home vital signs monitoring platforms market is forecast to grow from USD 614 mn in 2026 to USD 2.5 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 15.0%
Hospital-at-Home Vital Signs Monitoring Platforms market value, 2025 to 2036Market value by year. 2025: USD 520 mn; 2026: USD 614 mn; 2027: USD 706 mn; 2028: USD 811 mn; 2029: USD 933 mn; 2030: USD 1.1 bn; 2031: USD 1.2 bn; 2032: USD 1.4 bn; 2033: USD 1.6 bn; 2034: USD 1.9 bn; 2035: USD 2.2 bn; 2036: USD 2.5 bn. Compound annual growth rate 2026 to 2036: 15.0%.2025614 mn20261.2 bn20312.5 bn203615.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 614 mn
2027USD 706 mn
2028USD 811 mn
2029USD 933 mn
2030USD 1.1 bn
2031USD 1.2 bn
2032USD 1.4 bn
2033USD 1.6 bn
2034USD 1.9 bn
2035USD 2.2 bn
2036USD 2.5 bn

Hospital-at-Home Vital Signs Monitoring Platforms market segmentation

By component

Exhibit 2Wearables and monitoring devices is the largest segment by component, with 40.0% of 2026 revenueEstimated share of 2026 global revenue, by component
Hospital-at-Home Vital Signs Monitoring Platforms market share by component, 2026Share of 2026 revenue by component. Wearables and monitoring devices: 40.0%; Software platforms: 36.0%; Services and integration: 24.0%.Wearables and monitoring devices40.0%Software platforms36.0%Services and integration24.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Wearables and monitoring devices40.0%34.1%USD 245 mn13.2%
Software platforms36.0%43.5%USD 221 mn17.2%
Services and integration24.0%22.4%USD 147 mn14.2%

By care type

Exhibit 3Acute care substitution adds the most revenue by care type, growing from USD 344 mn in 2026 to USD 1.5 bn by 2036Estimated revenue in USD by care type, 2026 and 2036 forecast
Hospital-at-Home Vital Signs Monitoring Platforms market by care type, 2026 and 2036Revenue by care type in 2026 and 2036. Acute care substitution: USD 344 mn in 2026, USD 1.5 bn in 2036, change +330%; Post-acute recovery: USD 184 mn in 2026, USD 665 mn in 2036, change +261%; Oncology and infusion at home: USD 86 mn in 2026, USD 339 mn in 2036, change +294%.20262036 forecastChangeAcute care substitution+330%344 mn1.5 bnPost-acute recovery+261%184 mn665 mnOncology and infusion at home+294%86 mn339 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Acute care substitution56.0%59.5%USD 344 mn15.7%
Post-acute recovery30.0%26.8%USD 184 mn13.7%
Oncology and infusion at home14.0%13.7%USD 86 mn14.7%

By vital sign

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Heart rate and electrocardiogram28.0%27.0%USD 172 mn14.6%
Blood pressure22.0%20.0%USD 135 mn13.9%
Oxygen saturation and respiration26.0%26.0%USD 160 mn15.0%
Temperature, glucose and other24.0%27.0%USD 147 mn16.4%

By wearability

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Patch type36.0%38.0%USD 221 mn15.6%
Wrist-worn28.0%28.0%USD 172 mn15.0%
Contact-based peripherals36.0%34.0%USD 221 mn14.3%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Health systems60.0%56.0%USD 368 mn14.2%
Payers18.0%20.0%USD 110 mn16.2%
Independent providers22.0%24.0%USD 135 mn16.0%

Top 25 countries for hospital-at-home vital signs monitoring platforms by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 94.0% of 2026 revenue and the 25 countries below together hold 98.4%.

Exhibit 4United States is the largest country market at USD 393 mn in 2026, and the three largest countries hold 74.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Hospital-at-Home Vital Signs Monitoring Platforms market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 393 mn, 64.0%; United Kingdom: USD 37 mn, 6.0%; Australia: USD 25 mn, 4.0%; Germany: USD 25 mn, 4.0%; Spain: USD 18 mn, 3.0%; Israel: USD 18 mn, 3.0%; Canada: USD 18 mn, 3.0%; Japan: USD 18 mn, 3.0%; France: USD 12 mn, 2.0%; Singapore: USD 12 mn, 2.0%.United States393 mn 64.0%United Kingdom37 mn 6.0%Australia25 mn 4.0%Germany25 mn 4.0%Spain18 mn 3.0%Israel18 mn 3.0%Canada18 mn 3.0%Japan18 mn 3.0%France12 mn 2.0%Singapore12 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 393 mn64.0%USD 1.6 bn15.2%
2United KingdomUSD 37 mn6.0%USD 144 mn14.6%
3AustraliaUSD 25 mn4.0%USD 102 mn15.3%
4GermanyUSD 25 mn4.0%USD 92 mn14.1%
5SpainUSD 18 mn3.0%USD 70 mn14.2%
6IsraelUSD 18 mn3.0%USD 74 mn15.0%
7CanadaUSD 18 mn3.0%USD 72 mn14.6%
8JapanUSD 18 mn3.0%USD 67 mn13.8%
9FranceUSD 12 mn2.0%USD 47 mn14.4%
10SingaporeUSD 12 mn2.0%USD 52 mn15.6%
11ItalyUSD 2.6 mn0.4%USD 9.7 mn13.9%
12NetherlandsUSD 2.3 mn0.4%USD 8.4 mn14.0%
13ChinaUSD 2.3 mn0.4%USD 13 mn18.8%
14South KoreaUSD 2.3 mn0.4%USD 8.4 mn14.0%
15BrazilUSD 1.9 mn0.3%USD 8.7 mn16.4%
16SwitzerlandUSD 1.9 mn0.3%USD 7.0 mn13.8%
17SwedenUSD 1.9 mn0.3%USD 7.0 mn13.8%
18IndiaUSD 1.5 mn0.2%USD 8.4 mn18.6%
19Saudi ArabiaUSD 1.5 mn0.2%USD 7.0 mn16.3%
20United Arab EmiratesUSD 1.5 mn0.2%USD 7.0 mn16.3%
21BelgiumUSD 1.5 mn0.2%USD 5.7 mn14.1%
22DenmarkUSD 1.5 mn0.2%USD 5.7 mn14.1%
23IrelandUSD 1.5 mn0.2%USD 5.7 mn14.1%
24NorwayUSD 1.2 mn0.2%USD 4.2 mn13.7%
25MexicoUSD 1.2 mn0.2%USD 5.2 mn16.2%
Rest of worldUSD 10 mn1.6%USD 41 mn14.9%
Exhibit 5United States and United Kingdom account for 71% of the USD 1.9 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Hospital-at-Home Vital Signs Monitoring Platforms market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 614 mn. United States: +USD 1.2 bn; United Kingdom: +USD 107 mn; Australia: +USD 77 mn; Germany: +USD 67 mn; Israel: +USD 56 mn; 20 other countries: +USD 312 mn; Rest of world: +USD 31 mn. Market value 2036: USD 2.5 bn.Market value 2026614 mnUnited States+1.2 bnUnited Kingdom+107 mnAustralia+77 mnGermany+67 mnIsrael+56 mn20 other countries+312 mnRest of world+31 mnMarket value 20362.5 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Philips
  • Masimo
  • GE HealthCare
  • Medtronic
  • Baxter
  • Omron Healthcare

Group 2: Regional and specialist players

  • BioIntelliSense
  • Vivalink
  • Current Health
  • DispatchHealth
  • Biofourmis
  • Health Recovery Solutions
  • Withings
  • Sensium

Group 3: Emerging and niche players

  • Inbound Health
  • Biobeat
  • Doccla
  • Vitls
  • Sibel Health
  • Spry Health

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the hospital-at-home vital signs monitoring platforms market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 15.0% is calculated from the resulting values.

The market is divided by component, by care type, by vital sign, by wearability, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the hospital-at-home vital signs monitoring platforms market?

The global hospital-at-home vital signs monitoring platforms market is estimated at USD 520 mn in 2025 and USD 614 mn in 2026.

How fast will the hospital-at-home vital signs monitoring platforms market grow?

It is forecast to reach USD 2.5 bn by 2036, a compound annual growth rate of 15.0% from 2026, an increase of USD 1.9 bn.

Which country is the largest market for hospital-at-home vital signs monitoring platforms?

United States is the largest market by revenue at USD 393 mn in 2026, 64.0% of the global total. The three largest countries together hold 74.0%.

Which country is growing fastest?

Among the ten largest markets, Singapore is growing fastest at 15.6% a year from 2026 to 2036.

Which hospital-at-home vital signs monitoring platforms segment is largest?

In the by component split, Wearables and monitoring devices is the largest segment with 40.0% of 2026 revenue.

Who are the leading hospital-at-home vital signs monitoring platforms companies?

Global leaders include Philips, Masimo, GE HealthCare, Medtronic.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Hospital-at-Home Monitoring Platforms Immunoadsorption Columns →

All Healthcare markets →

Request a sample